Trial Outcomes & Findings for Study to Evaluate the PICO 14 Negative Pressure Wound Therapy System in the Management of Acute and Chronic Wounds (NCT NCT05234632)
NCT ID: NCT05234632
Last Updated: 2025-06-06
Results Overview
Delivery of nominal -80mmHg negative pressure over the treatment period was measured by download of the built-in data chip from the PICO 14 devices to collect NPWT delivery status. This data was summarized to provide the average negative pressure delivery overall and for both closed incisions and chronic/dehisced surgical wounds.
TERMINATED
45 participants
Day 30
2025-06-06
Participant Flow
Overall, 45 participants were enrolled to the study at 6 sites. There was one (1) screen failure, leaving 44 subjects (25 closed incisions; 19 chronic wounds) receiving PICO 14 NPWT treatment forming the safety analysis set (SAF).
Participant milestones
| Measure |
PICO 14 Closed Incisions
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
|---|---|---|
|
Overall Study
STARTED
|
25
|
19
|
|
Overall Study
COMPLETED
|
20
|
13
|
|
Overall Study
NOT COMPLETED
|
5
|
6
|
Reasons for withdrawal
| Measure |
PICO 14 Closed Incisions
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
|---|---|---|
|
Overall Study
Participant Withdrawn: Non-Compliance
|
1
|
0
|
|
Overall Study
Withdrawal by Subject
|
2
|
0
|
|
Overall Study
Adverse Event
|
0
|
4
|
|
Overall Study
Physician Decision
|
1
|
1
|
|
Overall Study
Participant tested positive for COVID-19 and is in isolation
|
0
|
1
|
|
Overall Study
Withdrawn by participant upon experiencing Adverse Event.
|
1
|
0
|
Baseline Characteristics
Study to Evaluate the PICO 14 Negative Pressure Wound Therapy System in the Management of Acute and Chronic Wounds
Baseline characteristics by cohort
| Measure |
PICO 14 Closed Incisions
n=25 Participants
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Chronic/Dehisced Surgical Wounds
n=19 Participants
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
Total
n=44 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
71.6 years
STANDARD_DEVIATION 10.2 • n=5 Participants
|
71.3 years
STANDARD_DEVIATION 16.3 • n=7 Participants
|
71.5 years
STANDARD_DEVIATION 13.0 • n=5 Participants
|
|
Sex: Female, Male
Female
|
16 Participants
n=5 Participants
|
13 Participants
n=7 Participants
|
29 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
9 Participants
n=5 Participants
|
6 Participants
n=7 Participants
|
15 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Race · Caucasian
|
25 Participants
n=5 Participants
|
15 Participants
n=7 Participants
|
40 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Race · Black
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Race · Asian
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Race · Other
|
0 Participants
n=5 Participants
|
4 Participants
n=7 Participants
|
4 Participants
n=5 Participants
|
|
Region of Enrollment
United Kingdom
|
25 participants
n=5 Participants
|
16 participants
n=7 Participants
|
41 participants
n=5 Participants
|
|
Region of Enrollment
Germany
|
0 participants
n=5 Participants
|
3 participants
n=7 Participants
|
3 participants
n=5 Participants
|
|
Body Mass Index (BMI)
|
29.1 kg/m^2
STANDARD_DEVIATION 4.6 • n=5 Participants
|
30.0 kg/m^2
STANDARD_DEVIATION 9.8 • n=7 Participants
|
29.5 kg/m^2
STANDARD_DEVIATION 7.1 • n=5 Participants
|
PRIMARY outcome
Timeframe: Day 30Population: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated.
Delivery of nominal -80mmHg negative pressure over the treatment period was measured by download of the built-in data chip from the PICO 14 devices to collect NPWT delivery status. This data was summarized to provide the average negative pressure delivery overall and for both closed incisions and chronic/dehisced surgical wounds.
Outcome measures
| Measure |
PICO 14 Closed Incisions
n=18 Participants
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Chronic/Dehisced Surgical Wounds
n=13 Participants
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
n=31 Participants
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
|---|---|---|---|
|
Delivery of Nominal -80mmHg Negative Pressure
|
-77.2 millimeters of mercury (mmHg)
Standard Deviation 7.7
|
-74.7 millimeters of mercury (mmHg)
Standard Deviation 11.4
|
-76.2 millimeters of mercury (mmHg)
Standard Deviation 9.3
|
PRIMARY outcome
Timeframe: Up to 30 DaysPopulation: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated.
Exudate management was measured by the number of participants with no exudate leaks identified by the clinician at any point over the treatment period, up to 30 days.
Outcome measures
| Measure |
PICO 14 Closed Incisions
n=20 Participants
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Chronic/Dehisced Surgical Wounds
n=13 Participants
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
n=33 Participants
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
|---|---|---|---|
|
Exudate Management: Occurrence of No Exudate Leaks
|
13 Participants
|
8 Participants
|
21 Participants
|
SECONDARY outcome
Timeframe: Day 14 and Day 30Population: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated.
The Patient and Observer Scar Assessment Scale (POSAS) is a comprehensive scale that is designed for the evaluation of all types of scars by professionals and patients. The POSAS consists of two parts: a Patient Scale and an Observer Scale. Both scales contain six items that are scored numerically and make up a 'Total Score' of the Patient and Observer Scale. Each item of both scales has a 10-point score, with 10 indicating the worst imaginable scar or sensation. The lowest score is '1', and corresponds to the situation of normal skin (normal pigmentation, no itching etc.), and goes up to the worst imaginable. The Total Score is provided for both the Patient Scale and Observer Scale at Day 14 \& Day 30. The Total Score for both scales was calculated by summing up the scores of each of the six items. The Total Score ranged from 6 to 60 with a lower score indicating a better outcome.
Outcome measures
| Measure |
PICO 14 Closed Incisions
n=20 Participants
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
|---|---|---|---|
|
Scar Quality Measured by The Patient and Observer Scar Assessment Scale (POSAS): Closed Incision Only
Day 14: Patient Scale Total Score
|
18.9 score on a scale
Standard Deviation 11.9
|
—
|
—
|
|
Scar Quality Measured by The Patient and Observer Scar Assessment Scale (POSAS): Closed Incision Only
Day 14: Observer Scale Total Score
|
16.3 score on a scale
Standard Deviation 9
|
—
|
—
|
|
Scar Quality Measured by The Patient and Observer Scar Assessment Scale (POSAS): Closed Incision Only
Day 30: Patient Scale Total Score
|
19.5 score on a scale
Standard Deviation 10.6
|
—
|
—
|
|
Scar Quality Measured by The Patient and Observer Scar Assessment Scale (POSAS): Closed Incision Only
Day 30: Observer Scale Total Score
|
13.7 score on a scale
Standard Deviation 7.4
|
—
|
—
|
SECONDARY outcome
Timeframe: Day 7, Day 14, and Day 30Population: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated. The FAS population for this outcome measure includes only participants with Closed Incisions identified as not healed (i.e., not fully closed/epithelialized).
Incidence of Surgical Site Infections (SSI) as defined by The Centers for Disease Control and Prevention (CDC) criteria, for any incision that had not healed by the given assessment at Day 7, Day 14, and Day 30. The number of participants with an incision that is clinically infected were categorized as either 'Yes' or 'No' (e.g., Is Incision Clinically Infected: Yes or No).
Outcome measures
| Measure |
PICO 14 Closed Incisions
n=8 Participants
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
|---|---|---|---|
|
Number of Participants With Surgical Site Infections (SSC): Closed Incisions Only
Day 7: Is Incision Clinically Infected · Yes
|
0 Participants
|
—
|
—
|
|
Number of Participants With Surgical Site Infections (SSC): Closed Incisions Only
Day 7: Is Incision Clinically Infected · No
|
8 Participants
|
—
|
—
|
|
Number of Participants With Surgical Site Infections (SSC): Closed Incisions Only
Day 14: Is Incision Clinically Infected · Yes
|
2 Participants
|
—
|
—
|
|
Number of Participants With Surgical Site Infections (SSC): Closed Incisions Only
Day 14: Is Incision Clinically Infected · No
|
0 Participants
|
—
|
—
|
|
Number of Participants With Surgical Site Infections (SSC): Closed Incisions Only
Day 30: Is Incision Clinically Infected · Yes
|
0 Participants
|
—
|
—
|
|
Number of Participants With Surgical Site Infections (SSC): Closed Incisions Only
Day 30: Is Incision Clinically Infected · No
|
2 Participants
|
—
|
—
|
SECONDARY outcome
Timeframe: Day 7, Day 14, and Day 30Population: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated. The FAS population for this outcome measure includes only participants with Closed Incisions identified as not healed (i.e., not fully closed/epithelialized).
Incidence of Surgical Site Complication (SSC) for any incision that had not healed by the given assessment at Day 7, Day 14, and Day 30. The number of participants where dehiscence of incision occurred, were categorized as either 'Yes' or 'No' (e.g., Incision dehisced: Yes or No).
Outcome measures
| Measure |
PICO 14 Closed Incisions
n=8 Participants
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
|---|---|---|---|
|
Number of Participants With Surgical Site Complication (SSC): Closed Incisions Only
Day 7: Incision Dehisced · Yes
|
0 Participants
|
—
|
—
|
|
Number of Participants With Surgical Site Complication (SSC): Closed Incisions Only
Day 7: Incision Dehisced · No
|
8 Participants
|
—
|
—
|
|
Number of Participants With Surgical Site Complication (SSC): Closed Incisions Only
Day 14: Incision Dehisced · Yes
|
1 Participants
|
—
|
—
|
|
Number of Participants With Surgical Site Complication (SSC): Closed Incisions Only
Day 14: Incision Dehisced · No
|
1 Participants
|
—
|
—
|
|
Number of Participants With Surgical Site Complication (SSC): Closed Incisions Only
Day 30: Incision Dehisced · Yes
|
1 Participants
|
—
|
—
|
|
Number of Participants With Surgical Site Complication (SSC): Closed Incisions Only
Day 30: Incision Dehisced · No
|
1 Participants
|
—
|
—
|
SECONDARY outcome
Timeframe: Day 7, Day 14, and Day 30Population: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Closed Incisions only.
The clinician assessed the condition of the surrounding skin of closed incisions at Day 7, Day 14, and Day 30. The condition of skin was categorized as the number of participants where any of the following characteristics apply: * Healthy * Fragile * Inflamed * Erythematous * Oedematous * Eczematous * Macerated * Bruising * Dry and flaky * Other
Outcome measures
| Measure |
PICO 14 Closed Incisions
n=22 Participants
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
|---|---|---|---|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at 7, 14 and 30 Days: Closed Incisions Only
Day 14: Other
|
0 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at 7, 14 and 30 Days: Closed Incisions Only
Day 30: Healthy
|
20 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at 7, 14 and 30 Days: Closed Incisions Only
Day 7: Healthy
|
18 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at 7, 14 and 30 Days: Closed Incisions Only
Day 7: Fragile
|
0 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at 7, 14 and 30 Days: Closed Incisions Only
Day 7: Inflamed
|
0 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at 7, 14 and 30 Days: Closed Incisions Only
Day 7: Erythematous
|
0 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at 7, 14 and 30 Days: Closed Incisions Only
Day 7: Oedematous
|
0 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at 7, 14 and 30 Days: Closed Incisions Only
Day 7: Eczematous
|
0 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at 7, 14 and 30 Days: Closed Incisions Only
Day 7: Macerated
|
0 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at 7, 14 and 30 Days: Closed Incisions Only
Day 7: Bruising
|
11 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at 7, 14 and 30 Days: Closed Incisions Only
Day 7: Dry and flaky
|
0 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at 7, 14 and 30 Days: Closed Incisions Only
Day 7: Other
|
0 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at 7, 14 and 30 Days: Closed Incisions Only
Day 14: Healthy
|
15 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at 7, 14 and 30 Days: Closed Incisions Only
Day 14: Fragile
|
1 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at 7, 14 and 30 Days: Closed Incisions Only
Day 14: Inflamed
|
1 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at 7, 14 and 30 Days: Closed Incisions Only
Day 14: Erythematous
|
2 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at 7, 14 and 30 Days: Closed Incisions Only
Day 14: Oedematous
|
1 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at 7, 14 and 30 Days: Closed Incisions Only
Day 14: Eczematous
|
0 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at 7, 14 and 30 Days: Closed Incisions Only
Day 14: Macerated
|
2 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at 7, 14 and 30 Days: Closed Incisions Only
Day 14: Bruising
|
4 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at 7, 14 and 30 Days: Closed Incisions Only
Day 14: Dry and flaky
|
1 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at 7, 14 and 30 Days: Closed Incisions Only
Day 30: Fragile
|
0 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at 7, 14 and 30 Days: Closed Incisions Only
Day 30: Inflamed
|
0 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at 7, 14 and 30 Days: Closed Incisions Only
Day 30: Erythematous
|
1 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at 7, 14 and 30 Days: Closed Incisions Only
Day 30: Oedematous
|
0 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at 7, 14 and 30 Days: Closed Incisions Only
Day 30: Eczematous
|
0 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at 7, 14 and 30 Days: Closed Incisions Only
Day 30: Macerated
|
1 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at 7, 14 and 30 Days: Closed Incisions Only
Day 30: Bruising
|
0 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at 7, 14 and 30 Days: Closed Incisions Only
Day 30: Dry and flaky
|
1 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at 7, 14 and 30 Days: Closed Incisions Only
Day 30: Other
|
0 Participants
|
—
|
—
|
SECONDARY outcome
Timeframe: Up to 14 DaysPopulation: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Closed Incisions only.
Level of pain on dressing application, during wear and at dressing removal assessed by Visual Analog Score (VAS) scale over the 14 day treatment period. The VAS scale ranges from 0-10 with 0 being no pain and 10 being extreme pain.
Outcome measures
| Measure |
PICO 14 Closed Incisions
n=47 Dressings
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
|---|---|---|---|
|
Level of Pain - Visual Analog Score (VAS): Closed Incisions Only
Level of Pain: Dressing Application
|
0.5 score on a scale
Standard Deviation 1.3
|
—
|
—
|
|
Level of Pain - Visual Analog Score (VAS): Closed Incisions Only
Level of Pain: During Wear
|
2.5 score on a scale
Standard Deviation 2.5
|
—
|
—
|
|
Level of Pain - Visual Analog Score (VAS): Closed Incisions Only
Level of Pain: Dressing Removal
|
1.3 score on a scale
Standard Deviation 1.9
|
—
|
—
|
SECONDARY outcome
Timeframe: Day 7, Day 14, and Day 30Population: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Closed Incisions only.
Patient satisfaction in performance at Day 7, Day 14, and Day 30 (follow-up) measured by response of 'Yes' or 'No' to the following: * Overall performance * Comfort during wear * Noise level * Discreetness * Portability
Outcome measures
| Measure |
PICO 14 Closed Incisions
n=20 Participants
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
|---|---|---|---|
|
Patient Satisfaction During Wear - Performance: Closed Incisions Only
Day 7: Overall performance · Yes
|
20 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Performance: Closed Incisions Only
Day 7: Overall performance · No
|
0 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Performance: Closed Incisions Only
Day 7: Comfort during wear · Yes
|
19 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Performance: Closed Incisions Only
Day 7: Comfort during wear · No
|
1 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Performance: Closed Incisions Only
Day 7: Noise level · Yes
|
18 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Performance: Closed Incisions Only
Day 7: Noise level · No
|
2 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Performance: Closed Incisions Only
Day 7: Discreetness · Yes
|
20 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Performance: Closed Incisions Only
Day 7: Discreetness · No
|
0 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Performance: Closed Incisions Only
Day 7: Portability · Yes
|
18 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Performance: Closed Incisions Only
Day 7: Portability · No
|
2 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Performance: Closed Incisions Only
Day 14: Overall performance · Yes
|
18 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Performance: Closed Incisions Only
Day 14: Overall performance · No
|
1 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Performance: Closed Incisions Only
Day 14: Comfort during wear · Yes
|
16 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Performance: Closed Incisions Only
Day 14: Comfort during wear · No
|
3 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Performance: Closed Incisions Only
Day 14: Noise level · Yes
|
16 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Performance: Closed Incisions Only
Day 14: Noise level · No
|
3 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Performance: Closed Incisions Only
Day 14: Discreetness · Yes
|
17 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Performance: Closed Incisions Only
Day 14: Discreetness · No
|
2 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Performance: Closed Incisions Only
Day 14: Portability · Yes
|
13 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Performance: Closed Incisions Only
Day 14: Portability · No
|
6 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Performance: Closed Incisions Only
Day 30: Overall performance · Yes
|
13 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Performance: Closed Incisions Only
Day 30: Overall performance · No
|
0 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Performance: Closed Incisions Only
Day 30: Comfort during wear · Yes
|
11 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Performance: Closed Incisions Only
Day 30: Comfort during wear · No
|
2 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Performance: Closed Incisions Only
Day 30: Noise level · Yes
|
10 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Performance: Closed Incisions Only
Day 30: Noise level · No
|
3 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Performance: Closed Incisions Only
Day 30: Discreetness · Yes
|
13 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Performance: Closed Incisions Only
Day 30: Discreetness · No
|
0 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Performance: Closed Incisions Only
Day 30: Portability · Yes
|
12 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Performance: Closed Incisions Only
Day 30: Portability · No
|
1 Participants
|
—
|
—
|
SECONDARY outcome
Timeframe: Day 7, Day 14, and Day 30Population: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Closed Incisions only.
Patient satisfaction during wear in interference with daily living at Day 7, Day 14, and Day 30 (follow-up) measured by response of 'Yes' or 'No' to the following: * Showering * Sleeping * Socializing * Working
Outcome measures
| Measure |
PICO 14 Closed Incisions
n=20 Participants
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
|---|---|---|---|
|
Patient Satisfaction During Wear - Interference With Daily Living: Closed Incisions Only
Day 7: Showering · Yes
|
8 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Interference With Daily Living: Closed Incisions Only
Day 7: Showering · No
|
3 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Interference With Daily Living: Closed Incisions Only
Day 7: Sleeping · Yes
|
18 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Interference With Daily Living: Closed Incisions Only
Day 7: Sleeping · No
|
2 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Interference With Daily Living: Closed Incisions Only
Day 7: Socializing · Yes
|
13 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Interference With Daily Living: Closed Incisions Only
Day 7: Socializing · No
|
0 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Interference With Daily Living: Closed Incisions Only
Day 7: Working · Yes
|
2 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Interference With Daily Living: Closed Incisions Only
Day 7: Working · No
|
1 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Interference With Daily Living: Closed Incisions Only
Day 14: Showering · Yes
|
10 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Interference With Daily Living: Closed Incisions Only
Day 14: Showering · No
|
3 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Interference With Daily Living: Closed Incisions Only
Day 14: Sleeping · Yes
|
16 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Interference With Daily Living: Closed Incisions Only
Day 14: Sleeping · No
|
3 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Interference With Daily Living: Closed Incisions Only
Day 14: Socializing · Yes
|
16 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Interference With Daily Living: Closed Incisions Only
Day 14: Socializing · No
|
0 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Interference With Daily Living: Closed Incisions Only
Day 14: Working · Yes
|
2 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Interference With Daily Living: Closed Incisions Only
Day 14: Working · No
|
3 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Interference With Daily Living: Closed Incisions Only
Day 30: Showering · Yes
|
5 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Interference With Daily Living: Closed Incisions Only
Day 30: Showering · No
|
2 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Interference With Daily Living: Closed Incisions Only
Day 30: Sleeping · Yes
|
11 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Interference With Daily Living: Closed Incisions Only
Day 30: Sleeping · No
|
2 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Interference With Daily Living: Closed Incisions Only
Day 30: Socializing · Yes
|
11 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Interference With Daily Living: Closed Incisions Only
Day 30: Socializing · No
|
1 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Interference With Daily Living: Closed Incisions Only
Day 30: Working · Yes
|
4 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Interference With Daily Living: Closed Incisions Only
Day 30: Working · No
|
1 Participants
|
—
|
—
|
SECONDARY outcome
Timeframe: Up to 14 daysPopulation: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Closed Incisions only.
Ease of application and removal of the PICO 14 dressing for Closed Incisions determined by overall count of dressings applied/removed based on responses to the questions "Was it easy to apply the dressing" and "Was it easy to remove the dressing" as either 'Yes' or 'No'.
Outcome measures
| Measure |
PICO 14 Closed Incisions
n=48 dressings
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
|---|---|---|---|
|
Ease of Application and Removal: Closed Incisions Only
Was it easy to apply the dressing · Yes
|
48 dressings
|
—
|
—
|
|
Ease of Application and Removal: Closed Incisions Only
Was it easy to apply the dressing · No
|
0 dressings
|
—
|
—
|
|
Ease of Application and Removal: Closed Incisions Only
Was it easy to remove the dressing · Yes
|
46 dressings
|
—
|
—
|
|
Ease of Application and Removal: Closed Incisions Only
Was it easy to remove the dressing · No
|
2 dressings
|
—
|
—
|
SECONDARY outcome
Timeframe: Up to 14 daysPopulation: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Closed Incisions only.
Overall dressing wear time in days for Closed Incisions only.
Outcome measures
| Measure |
PICO 14 Closed Incisions
n=51 dressings
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
|---|---|---|---|
|
Dressing Wear Time: Closed Incisions Only
|
5.7 days
Standard Deviation 2.1
|
—
|
—
|
SECONDARY outcome
Timeframe: Up to 14 daysPopulation: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Closed Incisions only.
Dressing conformability to the closed incision wound measured by the number of responses to the question "Was the dressing conformable on the incision/wound?" as either 'Yes' or 'No'.
Outcome measures
| Measure |
PICO 14 Closed Incisions
n=48 dressings
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
|---|---|---|---|
|
Dressing Conformability: Closed Incisions Only
Yes
|
48 dressings
|
—
|
—
|
|
Dressing Conformability: Closed Incisions Only
No
|
0 dressings
|
—
|
—
|
SECONDARY outcome
Timeframe: Up to 14 daysPopulation: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Closed Incisions only.
Dressing change frequency summarized as the number of dressings used per participants for Closed Incisions.
Outcome measures
| Measure |
PICO 14 Closed Incisions
n=22 Participants
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
|---|---|---|---|
|
Number of Dressings Used: Closed Incisions Only
|
2.2 dressings per participant
Standard Deviation 1.0
|
—
|
—
|
SECONDARY outcome
Timeframe: Up to 14 daysPopulation: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Closed Incisions only.
Reason for dressing change for Closed Incisions only. Count of occurrences by dressing were categorized as 'Yes' or 'No': * Routine dressing change * Inadequate exudate management * Pain/discomfort * Dressing damaged * Dressing fell off * Patient removed dressing * Adverse Event * Surgical procedure * Safety alarm * Dressing components not in place * No vacuum * other
Outcome measures
| Measure |
PICO 14 Closed Incisions
n=51 dressings
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
|---|---|---|---|
|
Reason for Dressing Change: Closed Incisions Only
Surgical procedure · No
|
51 dressings
|
—
|
—
|
|
Reason for Dressing Change: Closed Incisions Only
Routine dressing change · Yes
|
37 dressings
|
—
|
—
|
|
Reason for Dressing Change: Closed Incisions Only
Routine dressing change · No
|
14 dressings
|
—
|
—
|
|
Reason for Dressing Change: Closed Incisions Only
Inadequate exudate management · Yes
|
5 dressings
|
—
|
—
|
|
Reason for Dressing Change: Closed Incisions Only
Inadequate exudate management · No
|
46 dressings
|
—
|
—
|
|
Reason for Dressing Change: Closed Incisions Only
Pain/discomfort · Yes
|
0 dressings
|
—
|
—
|
|
Reason for Dressing Change: Closed Incisions Only
Pain/discomfort · No
|
51 dressings
|
—
|
—
|
|
Reason for Dressing Change: Closed Incisions Only
Dressing damaged · Yes
|
0 dressings
|
—
|
—
|
|
Reason for Dressing Change: Closed Incisions Only
Dressing damaged · No
|
51 dressings
|
—
|
—
|
|
Reason for Dressing Change: Closed Incisions Only
Dressing fell off · Yes
|
0 dressings
|
—
|
—
|
|
Reason for Dressing Change: Closed Incisions Only
Dressing fell off · No
|
51 dressings
|
—
|
—
|
|
Reason for Dressing Change: Closed Incisions Only
Patient removed dressing · Yes
|
1 dressings
|
—
|
—
|
|
Reason for Dressing Change: Closed Incisions Only
Patient removed dressing · No
|
50 dressings
|
—
|
—
|
|
Reason for Dressing Change: Closed Incisions Only
Adverse Event · Yes
|
4 dressings
|
—
|
—
|
|
Reason for Dressing Change: Closed Incisions Only
Adverse Event · No
|
47 dressings
|
—
|
—
|
|
Reason for Dressing Change: Closed Incisions Only
Surgical procedure · Yes
|
0 dressings
|
—
|
—
|
|
Reason for Dressing Change: Closed Incisions Only
Safety alarm · Yes
|
1 dressings
|
—
|
—
|
|
Reason for Dressing Change: Closed Incisions Only
Safety alarm · No
|
50 dressings
|
—
|
—
|
|
Reason for Dressing Change: Closed Incisions Only
Dressing components not in place · Yes
|
1 dressings
|
—
|
—
|
|
Reason for Dressing Change: Closed Incisions Only
Dressing components not in place · No
|
50 dressings
|
—
|
—
|
|
Reason for Dressing Change: Closed Incisions Only
No vacuum · Yes
|
2 dressings
|
—
|
—
|
|
Reason for Dressing Change: Closed Incisions Only
No vacuum · No
|
49 dressings
|
—
|
—
|
|
Reason for Dressing Change: Closed Incisions Only
Other · Yes
|
3 dressings
|
—
|
—
|
|
Reason for Dressing Change: Closed Incisions Only
Other · No
|
48 dressings
|
—
|
—
|
SECONDARY outcome
Timeframe: Day 14Population: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Closed Incisions only.
Acceptability of the device determined from the clinician's response (Yes/No) at discontinuation of therapy by participant (i.e., Day 14) to the question: Overall are you satisfied with the performance of the PICO 14 system (pump and PICO 14 dressing)?
Outcome measures
| Measure |
PICO 14 Closed Incisions
n=19 Participants
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
|---|---|---|---|
|
Clinician Acceptability of PICO 14 at Discontinuation of Therapy: Closed Incision Only
Yes
|
19 Participants
|
—
|
—
|
|
Clinician Acceptability of PICO 14 at Discontinuation of Therapy: Closed Incision Only
No
|
0 Participants
|
—
|
—
|
SECONDARY outcome
Timeframe: Day 0, Day 7, Day 14, Day 21, and Day 28Population: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Chronic and Dehisced Surgical Wounds only.
Count of participants with presence of infection as determined by the clinical signs and symptoms at Day 0, Day 7, Day 14, Day 21, and Day 28 for Chronic and Dehisced Surgical Wounds (i.e., clinically infected: 'Yes' or 'No').
Outcome measures
| Measure |
PICO 14 Closed Incisions
n=16 Participants
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
|---|---|---|---|
|
Number of Participants With Clinical Infection: Chronic and Dehisced Surgical Wounds Only
Day 0: Clinically infected · Yes
|
0 Participants
|
—
|
—
|
|
Number of Participants With Clinical Infection: Chronic and Dehisced Surgical Wounds Only
Day 0: Clinically infected · No
|
16 Participants
|
—
|
—
|
|
Number of Participants With Clinical Infection: Chronic and Dehisced Surgical Wounds Only
Day 7: Clinically infected · Yes
|
0 Participants
|
—
|
—
|
|
Number of Participants With Clinical Infection: Chronic and Dehisced Surgical Wounds Only
Day 7: Clinically infected · No
|
16 Participants
|
—
|
—
|
|
Number of Participants With Clinical Infection: Chronic and Dehisced Surgical Wounds Only
Day 14: Clinically infected · Yes
|
0 Participants
|
—
|
—
|
|
Number of Participants With Clinical Infection: Chronic and Dehisced Surgical Wounds Only
Day 14: Clinically infected · No
|
15 Participants
|
—
|
—
|
|
Number of Participants With Clinical Infection: Chronic and Dehisced Surgical Wounds Only
Day 21: Clinically infected · Yes
|
0 Participants
|
—
|
—
|
|
Number of Participants With Clinical Infection: Chronic and Dehisced Surgical Wounds Only
Day 21: Clinically infected · No
|
14 Participants
|
—
|
—
|
|
Number of Participants With Clinical Infection: Chronic and Dehisced Surgical Wounds Only
Day 28: Clinically infected · Yes
|
0 Participants
|
—
|
—
|
|
Number of Participants With Clinical Infection: Chronic and Dehisced Surgical Wounds Only
Day 28: Clinically infected · No
|
13 Participants
|
—
|
—
|
SECONDARY outcome
Timeframe: Screening and Day 28Population: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Chronic and Dehisced Surgical Wounds only.
Appearance of the wound by size measured by the length and width in centimeters at screening and Day 28 for Chronic and Dehisced Surgical Wounds only.
Outcome measures
| Measure |
PICO 14 Closed Incisions
n=16 Participants
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
|---|---|---|---|
|
Appearance of the Wound by Size: Chronic and Dehisced Surgical Wounds Only
Screening: Length
|
5.9 centimeters (cm)
Standard Deviation 5.2
|
—
|
—
|
|
Appearance of the Wound by Size: Chronic and Dehisced Surgical Wounds Only
Day 28: Length
|
3.1 centimeters (cm)
Standard Deviation 2.2
|
—
|
—
|
|
Appearance of the Wound by Size: Chronic and Dehisced Surgical Wounds Only
Screening: Width
|
4.5 centimeters (cm)
Standard Deviation 2.9
|
—
|
—
|
|
Appearance of the Wound by Size: Chronic and Dehisced Surgical Wounds Only
Day 28: Width
|
3.1 centimeters (cm)
Standard Deviation 2.4
|
—
|
—
|
SECONDARY outcome
Timeframe: Screening and Day 28Population: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Chronic and Dehisced Surgical Wounds only.
Appearance of the wound by depth measured in millimeters at screening and Day 28 for Chronic and Dehisced Surgical Wounds only.
Outcome measures
| Measure |
PICO 14 Closed Incisions
n=16 Participants
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
|---|---|---|---|
|
Appearance of the Wound by Depth: Chronic and Dehisced Surgical Wounds Only
Screening: Depth
|
10.6 millimeters (mm)
Standard Deviation 11.1
|
—
|
—
|
|
Appearance of the Wound by Depth: Chronic and Dehisced Surgical Wounds Only
Day 28: Depth
|
3.2 millimeters (mm)
Standard Deviation 5.7
|
—
|
—
|
SECONDARY outcome
Timeframe: Screening and Day 28Population: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Chronic and Dehisced Surgical Wounds only.
Appearance of the wound by number of participants with the presence of necrotic tissue (Yes/No) at screening and Day 28 for Chronic and Dehisced Surgical Wounds.
Outcome measures
| Measure |
PICO 14 Closed Incisions
n=16 Participants
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
|---|---|---|---|
|
Appearance of the Wound by Presence of Necrotic Tissue: Chronic and Dehisced Surgical Wounds Only
Day 28: Presence of Necrotic Tissue · Yes
|
3 Participants
|
—
|
—
|
|
Appearance of the Wound by Presence of Necrotic Tissue: Chronic and Dehisced Surgical Wounds Only
Screening: Presence of Necrotic Tissue · Yes
|
8 Participants
|
—
|
—
|
|
Appearance of the Wound by Presence of Necrotic Tissue: Chronic and Dehisced Surgical Wounds Only
Screening: Presence of Necrotic Tissue · No
|
8 Participants
|
—
|
—
|
|
Appearance of the Wound by Presence of Necrotic Tissue: Chronic and Dehisced Surgical Wounds Only
Day 28: Presence of Necrotic Tissue · No
|
10 Participants
|
—
|
—
|
SECONDARY outcome
Timeframe: Screening and Day 28Population: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Chronic and Dehisced Surgical Wounds with presence of necrotic tissue only.
Appearance of the wound by amount of necrotic tissue at screening and Day 28 for Chronic and Dehisced Surgical Wounds categorized as number of participants with: * \<25% of wound bed covered * 25% to 50% of wound covered * 50% to \< 75% of wound covered * 75% to 100% of wound covered
Outcome measures
| Measure |
PICO 14 Closed Incisions
n=8 Participants
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
|---|---|---|---|
|
Appearance of the Wound by Necrotic Tissue Amount: Chronic and Dehisced Surgical Wounds Only
Screening: Necrotic Tissue Amount · <25% of wound bed covered
|
5 Participants
|
—
|
—
|
|
Appearance of the Wound by Necrotic Tissue Amount: Chronic and Dehisced Surgical Wounds Only
Screening: Necrotic Tissue Amount · 25% to 50% of wound covered
|
2 Participants
|
—
|
—
|
|
Appearance of the Wound by Necrotic Tissue Amount: Chronic and Dehisced Surgical Wounds Only
Screening: Necrotic Tissue Amount · 50% to < 75% of wound covered
|
1 Participants
|
—
|
—
|
|
Appearance of the Wound by Necrotic Tissue Amount: Chronic and Dehisced Surgical Wounds Only
Screening: Necrotic Tissue Amount · 75% to 100% of wound covered
|
0 Participants
|
—
|
—
|
|
Appearance of the Wound by Necrotic Tissue Amount: Chronic and Dehisced Surgical Wounds Only
Day 28: Necrotic Tissue Amount · <25% of wound bed covered
|
2 Participants
|
—
|
—
|
|
Appearance of the Wound by Necrotic Tissue Amount: Chronic and Dehisced Surgical Wounds Only
Day 28: Necrotic Tissue Amount · 25% to 50% of wound covered
|
0 Participants
|
—
|
—
|
|
Appearance of the Wound by Necrotic Tissue Amount: Chronic and Dehisced Surgical Wounds Only
Day 28: Necrotic Tissue Amount · 50% to < 75% of wound covered
|
1 Participants
|
—
|
—
|
|
Appearance of the Wound by Necrotic Tissue Amount: Chronic and Dehisced Surgical Wounds Only
Day 28: Necrotic Tissue Amount · 75% to 100% of wound covered
|
0 Participants
|
—
|
—
|
SECONDARY outcome
Timeframe: Screening and Day 28Population: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Chronic and Dehisced Surgical Wounds with presence of necrotic tissue only.
Appearance of the wound by type of necrotic tissue at screening and Day 28 for Chronic and Dehisced Surgical Wounds categorized as number of participants with: * White/grey non-viable tissue * Non-adherent, yellow slough * Loosely adherent, yellow slough * Adherent, soft, black eschar * Firmly adherent, hard/black eschar
Outcome measures
| Measure |
PICO 14 Closed Incisions
n=8 Participants
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
|---|---|---|---|
|
Appearance of the Wound by Type of Necrotic Tissue: Chronic and Dehisced Surgical Wounds Only
Screening: Type of Necrotic Tissue · White/grey non-viable tissue
|
0 Participants
|
—
|
—
|
|
Appearance of the Wound by Type of Necrotic Tissue: Chronic and Dehisced Surgical Wounds Only
Screening: Type of Necrotic Tissue · Adherent, soft, black eschar
|
0 Participants
|
—
|
—
|
|
Appearance of the Wound by Type of Necrotic Tissue: Chronic and Dehisced Surgical Wounds Only
Screening: Type of Necrotic Tissue · Non-adherent, yellow slough
|
3 Participants
|
—
|
—
|
|
Appearance of the Wound by Type of Necrotic Tissue: Chronic and Dehisced Surgical Wounds Only
Screening: Type of Necrotic Tissue · Loosely adherent, yellow slough
|
5 Participants
|
—
|
—
|
|
Appearance of the Wound by Type of Necrotic Tissue: Chronic and Dehisced Surgical Wounds Only
Screening: Type of Necrotic Tissue · Firmly adherent, hard/black eschar
|
0 Participants
|
—
|
—
|
|
Appearance of the Wound by Type of Necrotic Tissue: Chronic and Dehisced Surgical Wounds Only
Day 28: Type of Necrotic Tissue · White/grey non-viable tissue
|
0 Participants
|
—
|
—
|
|
Appearance of the Wound by Type of Necrotic Tissue: Chronic and Dehisced Surgical Wounds Only
Day 28: Type of Necrotic Tissue · Non-adherent, yellow slough
|
1 Participants
|
—
|
—
|
|
Appearance of the Wound by Type of Necrotic Tissue: Chronic and Dehisced Surgical Wounds Only
Day 28: Type of Necrotic Tissue · Loosely adherent, yellow slough
|
2 Participants
|
—
|
—
|
|
Appearance of the Wound by Type of Necrotic Tissue: Chronic and Dehisced Surgical Wounds Only
Day 28: Type of Necrotic Tissue · Adherent, soft, black eschar
|
0 Participants
|
—
|
—
|
|
Appearance of the Wound by Type of Necrotic Tissue: Chronic and Dehisced Surgical Wounds Only
Day 28: Type of Necrotic Tissue · Firmly adherent, hard/black eschar
|
0 Participants
|
—
|
—
|
SECONDARY outcome
Timeframe: Screening and Day 28Population: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Chronic and Dehisced Surgical Wounds only.
Appearance of the wound by granulation tissue at screening and Day 28 for Chronic and Dehisced Surgical Wounds categorized as number of participants with: * Skin intact or partial thickness wound * Bright, beefy red; 75% to 100% of wound filled \&/or tissue overgrowth * Bright, beefy red; \< 75% \& \>25% of wound filled * Pink, \&/or dull, dusky red \&/or fills \<25% of wound * No granulation tissue present
Outcome measures
| Measure |
PICO 14 Closed Incisions
n=16 Participants
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
|---|---|---|---|
|
Appearance of the Wound by Granulation Tissue: Chronic and Dehisced Surgical Wounds Only
Screening: Granulation Tissue · Skin intact or partial thickness wound
|
0 Participants
|
—
|
—
|
|
Appearance of the Wound by Granulation Tissue: Chronic and Dehisced Surgical Wounds Only
Screening: Granulation Tissue · Bright, beefy red; 75% to 100% of wound filled &/or tissue overgrowth
|
7 Participants
|
—
|
—
|
|
Appearance of the Wound by Granulation Tissue: Chronic and Dehisced Surgical Wounds Only
Screening: Granulation Tissue · Bright, beefy red; < 75% & >25% of wound filled
|
6 Participants
|
—
|
—
|
|
Appearance of the Wound by Granulation Tissue: Chronic and Dehisced Surgical Wounds Only
Screening: Granulation Tissue · Pink, &/or dull, dusky red &/or fills <25% of wound
|
3 Participants
|
—
|
—
|
|
Appearance of the Wound by Granulation Tissue: Chronic and Dehisced Surgical Wounds Only
Screening: Granulation Tissue · No granulation tissue present
|
0 Participants
|
—
|
—
|
|
Appearance of the Wound by Granulation Tissue: Chronic and Dehisced Surgical Wounds Only
Day 28: Granulation Tissue · Skin intact or partial thickness wound
|
1 Participants
|
—
|
—
|
|
Appearance of the Wound by Granulation Tissue: Chronic and Dehisced Surgical Wounds Only
Day 28: Granulation Tissue · Bright, beefy red; 75% to 100% of wound filled &/or tissue overgrowth
|
5 Participants
|
—
|
—
|
|
Appearance of the Wound by Granulation Tissue: Chronic and Dehisced Surgical Wounds Only
Day 28: Granulation Tissue · Bright, beefy red; < 75% & >25% of wound filled
|
6 Participants
|
—
|
—
|
|
Appearance of the Wound by Granulation Tissue: Chronic and Dehisced Surgical Wounds Only
Day 28: Granulation Tissue · Pink, &/or dull, dusky red &/or fills <25% of wound
|
1 Participants
|
—
|
—
|
|
Appearance of the Wound by Granulation Tissue: Chronic and Dehisced Surgical Wounds Only
Day 28: Granulation Tissue · No granulation tissue present
|
0 Participants
|
—
|
—
|
SECONDARY outcome
Timeframe: Screening and Day 28Population: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Chronic and Dehisced Surgical Wounds only.
Appearance of the wound by epithelialization at screening and Day 28 for Chronic and Dehisced Surgical Wounds categorized as number of participants with: * 100% wound covered, surface intact * 75% to \< 100% wound covered \&/or epithelial tissue extends to \> 0.5 cm into wound bed * 50% to \< 75% wound covered \&/or epithelial tissue extends to \< 0.5 cm into wound bed * 25% to \< 50% wound covered * \< 25% wound covered
Outcome measures
| Measure |
PICO 14 Closed Incisions
n=16 Participants
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
|---|---|---|---|
|
Appearance of the Wound by Epithelialization: Chronic and Dehisced Surgical Wounds Only
Screening: Epithelialization · 100% wound covered, surface intact
|
0 Participants
|
—
|
—
|
|
Appearance of the Wound by Epithelialization: Chronic and Dehisced Surgical Wounds Only
Screening: Epithelialization · 75% to < 100% wound covered &/or epithelial tissue extends to > 0.5 cm into wound bed
|
0 Participants
|
—
|
—
|
|
Appearance of the Wound by Epithelialization: Chronic and Dehisced Surgical Wounds Only
Screening: Epithelialization · 50% to < 75% wound covered &/or epithelial tissue extends to < 0.5 cm into wound bed
|
0 Participants
|
—
|
—
|
|
Appearance of the Wound by Epithelialization: Chronic and Dehisced Surgical Wounds Only
Screening: Epithelialization · 25% to < 50% wound covered
|
0 Participants
|
—
|
—
|
|
Appearance of the Wound by Epithelialization: Chronic and Dehisced Surgical Wounds Only
Screening: Epithelialization · < 25% wound covered
|
16 Participants
|
—
|
—
|
|
Appearance of the Wound by Epithelialization: Chronic and Dehisced Surgical Wounds Only
Day 28: Epithelialization · 100% wound covered, surface intact
|
0 Participants
|
—
|
—
|
|
Appearance of the Wound by Epithelialization: Chronic and Dehisced Surgical Wounds Only
Day 28: Epithelialization · 75% to < 100% wound covered &/or epithelial tissue extends to > 0.5 cm into wound bed
|
1 Participants
|
—
|
—
|
|
Appearance of the Wound by Epithelialization: Chronic and Dehisced Surgical Wounds Only
Day 28: Epithelialization · 50% to < 75% wound covered &/or epithelial tissue extends to < 0.5 cm into wound bed
|
1 Participants
|
—
|
—
|
|
Appearance of the Wound by Epithelialization: Chronic and Dehisced Surgical Wounds Only
Day 28: Epithelialization · 25% to < 50% wound covered
|
2 Participants
|
—
|
—
|
|
Appearance of the Wound by Epithelialization: Chronic and Dehisced Surgical Wounds Only
Day 28: Epithelialization · < 25% wound covered
|
9 Participants
|
—
|
—
|
SECONDARY outcome
Timeframe: Screening and Day 28Population: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Chronic and Dehisced Surgical Wounds only.
Appearance of the wound by number of participants with presence of exudate (Yes/No) at screening and Day 28 for Chronic and Dehisced Surgical Wounds.
Outcome measures
| Measure |
PICO 14 Closed Incisions
n=16 Participants
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
|---|---|---|---|
|
Appearance of the Wound by Presence of Exudate: Chronic and Dehisced Surgical Wounds Only
Screening: Presence of Exudate · Yes
|
15 Participants
|
—
|
—
|
|
Appearance of the Wound by Presence of Exudate: Chronic and Dehisced Surgical Wounds Only
Screening: Presence of Exudate · No
|
1 Participants
|
—
|
—
|
|
Appearance of the Wound by Presence of Exudate: Chronic and Dehisced Surgical Wounds Only
Day 28: Presence of Exudate · Yes
|
12 Participants
|
—
|
—
|
|
Appearance of the Wound by Presence of Exudate: Chronic and Dehisced Surgical Wounds Only
Day 28: Presence of Exudate · No
|
1 Participants
|
—
|
—
|
SECONDARY outcome
Timeframe: Screening and Day 28Population: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Chronic and Dehisced Surgical Wounds with exudate present only.
Appearance of the wound by number of participants level of exudate at screening and Day 28 for Chronic and Dehisced Surgical Wounds categorized as: * Light * Moderate * Heavy
Outcome measures
| Measure |
PICO 14 Closed Incisions
n=15 Participants
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
|---|---|---|---|
|
Appearance of the Wound by Level of Exudate: Chronic and Dehisced Surgical Wounds Only
Day 28: Level of Exudate · Moderate
|
5 Participants
|
—
|
—
|
|
Appearance of the Wound by Level of Exudate: Chronic and Dehisced Surgical Wounds Only
Screening: Level of Exudate · Light
|
2 Participants
|
—
|
—
|
|
Appearance of the Wound by Level of Exudate: Chronic and Dehisced Surgical Wounds Only
Screening: Level of Exudate · Moderate
|
12 Participants
|
—
|
—
|
|
Appearance of the Wound by Level of Exudate: Chronic and Dehisced Surgical Wounds Only
Screening: Level of Exudate · Heavy
|
1 Participants
|
—
|
—
|
|
Appearance of the Wound by Level of Exudate: Chronic and Dehisced Surgical Wounds Only
Day 28: Level of Exudate · Light
|
6 Participants
|
—
|
—
|
|
Appearance of the Wound by Level of Exudate: Chronic and Dehisced Surgical Wounds Only
Day 28: Level of Exudate · Heavy
|
1 Participants
|
—
|
—
|
SECONDARY outcome
Timeframe: Day 0, Day 7, Day 14, Day 21, and Day 28Population: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Chronic and Dehisced Surgical Wounds only.
The clinician assessed the condition of the surrounding skin of Chronic and Dehisced Surgical Wounds at Day 0, Day 7, Day 14, Day 21, and Day 28. The condition of skin was categorized as the number of participants where any of the following characteristics apply: * Normal * Erythematous * Oedematous * Eczematous * Excoriated * Macerated * Indurated * Other
Outcome measures
| Measure |
PICO 14 Closed Incisions
n=16 Participants
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
|---|---|---|---|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 0 : Normal
|
7 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 0 : Erythematous
|
2 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 0 : Oedematous
|
4 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 0 : Eczematous
|
0 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 0 : Excoriated
|
1 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 0 : Macerated
|
3 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 0 : Indurated
|
0 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 0 : Other
|
2 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 7 : Normal
|
6 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 7 : Erythematous
|
2 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 7 : Oedematous
|
3 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 7 : Eczematous
|
0 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 7 : Excoriated
|
1 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 7 : Macerated
|
5 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 7 : Indurated
|
0 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 7 : Other
|
4 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 14 : Normal
|
5 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 14 : Erythematous
|
3 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 14 : Oedematous
|
3 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 14 : Eczematous
|
0 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 14 : Excoriated
|
3 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 14 : Macerated
|
5 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 14 : Indurated
|
0 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 14 : Other
|
3 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 21 : Normal
|
5 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 21 : Erythematous
|
1 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 21 : Oedematous
|
2 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 21 : Eczematous
|
1 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 21 : Excoriated
|
1 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 21 : Macerated
|
4 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 21 : Indurated
|
0 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 21 : Other
|
5 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 28 : Normal
|
4 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 28 : Erythematous
|
1 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 28 : Oedematous
|
1 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 28 : Eczematous
|
0 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 28 : Excoriated
|
2 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 28 : Macerated
|
4 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 28 : Indurated
|
0 Participants
|
—
|
—
|
|
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 28 : Other
|
3 Participants
|
—
|
—
|
SECONDARY outcome
Timeframe: Day 7, Day 14, Day 21, and Day 28Population: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Chronic and Dehisced Surgical Wounds only.
The reference wound area captured at each study visit. Percentage change in area calculated and summarized using a Wilcoxon Signed Rank test from baseline to all post-baseline study visits at Day 7, Day 14, Day 21, and Day 28.
Outcome measures
| Measure |
PICO 14 Closed Incisions
n=16 Participants
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
|---|---|---|---|
|
Percentage Change in Area of Wound: Chronic and Dehisced Surgical Wounds Only
Day 7
|
17.5 percent change in wound area
Standard Deviation 24.7
|
—
|
—
|
|
Percentage Change in Area of Wound: Chronic and Dehisced Surgical Wounds Only
Day 14
|
18.6 percent change in wound area
Standard Deviation 31.0
|
—
|
—
|
|
Percentage Change in Area of Wound: Chronic and Dehisced Surgical Wounds Only
Day 21
|
42.2 percent change in wound area
Standard Deviation 22.7
|
—
|
—
|
|
Percentage Change in Area of Wound: Chronic and Dehisced Surgical Wounds Only
Day 28
|
50.5 percent change in wound area
Standard Deviation 24.0
|
—
|
—
|
SECONDARY outcome
Timeframe: Day 7, Day 14, Day 21, and Day 28Population: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Chronic and Dehisced Surgical Wounds only.
The reference wound volume captured at each study visit. Percentage change in volume calculated and summarized using a Wilcoxon Signed Rank test from baseline to all post-baseline study visits at Day 7, Day 14, Day 21, and Day 28.
Outcome measures
| Measure |
PICO 14 Closed Incisions
n=15 Participants
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
|---|---|---|---|
|
Percentage Change in Volume of Wound: Chronic and Dehisced Surgical Wounds Only
Day 7
|
41.8 percent change in wound volume
Standard Deviation 30.3
|
—
|
—
|
|
Percentage Change in Volume of Wound: Chronic and Dehisced Surgical Wounds Only
Day 14
|
52.3 percent change in wound volume
Standard Deviation 32.8
|
—
|
—
|
|
Percentage Change in Volume of Wound: Chronic and Dehisced Surgical Wounds Only
Day 21
|
72.7 percent change in wound volume
Standard Deviation 30.8
|
—
|
—
|
|
Percentage Change in Volume of Wound: Chronic and Dehisced Surgical Wounds Only
Day 28
|
79.3 percent change in wound volume
Standard Deviation 24.7
|
—
|
—
|
SECONDARY outcome
Timeframe: Up to 28 daysPopulation: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Chronic and Dehisced Surgical Wounds only.
Level of pain on application, during wear and at dressing removal assessed by Visual Analog Score (VAS) scale over the 28 day treatment period. The VAS scale ranges from 0-10 with 0 being no pain and 10 being extreme pain.
Outcome measures
| Measure |
PICO 14 Closed Incisions
n=99 dressings
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
|---|---|---|---|
|
Level of Pain - Visual Analog Score (VAS): Chronic and Dehisced Surgical Wounds Only
Level of Pain: Dressing Application
|
0.4 score on a scale
Standard Deviation 1.4
|
—
|
—
|
|
Level of Pain - Visual Analog Score (VAS): Chronic and Dehisced Surgical Wounds Only
Level of Pain: During Wear
|
1.1 score on a scale
Standard Deviation 2.1
|
—
|
—
|
|
Level of Pain - Visual Analog Score (VAS): Chronic and Dehisced Surgical Wounds Only
Level of Pain: Dressing Removal
|
1.5 score on a scale
Standard Deviation 2.4
|
—
|
—
|
SECONDARY outcome
Timeframe: Day 14 and Day 28Population: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Chronic and Dehisced Surgical Wounds only.
Patient satisfaction in performance at Day 14 and Day 28 measured by response of 'Yes' or 'No' to the following: * Overall performance * Comfort during wear * Noise level * Discreetness * Portability
Outcome measures
| Measure |
PICO 14 Closed Incisions
n=15 Participants
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
|---|---|---|---|
|
Patient Satisfaction During Wear - Performance: Chronic and Dehisced Surgical Wounds Only
Day 14: Overall performance · Yes
|
15 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Performance: Chronic and Dehisced Surgical Wounds Only
Day 14: Overall performance · No
|
0 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Performance: Chronic and Dehisced Surgical Wounds Only
Day 14: Comfort during wear · Yes
|
15 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Performance: Chronic and Dehisced Surgical Wounds Only
Day 14: Comfort during wear · No
|
0 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Performance: Chronic and Dehisced Surgical Wounds Only
Day 14: Noise level · Yes
|
15 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Performance: Chronic and Dehisced Surgical Wounds Only
Day 14: Noise level · No
|
0 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Performance: Chronic and Dehisced Surgical Wounds Only
Day 14: Discreetness · Yes
|
15 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Performance: Chronic and Dehisced Surgical Wounds Only
Day 14: Discreetness · No
|
0 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Performance: Chronic and Dehisced Surgical Wounds Only
Day 14: Portability · Yes
|
15 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Performance: Chronic and Dehisced Surgical Wounds Only
Day 14: Portability · No
|
0 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Performance: Chronic and Dehisced Surgical Wounds Only
Day 28: Overall performance · Yes
|
13 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Performance: Chronic and Dehisced Surgical Wounds Only
Day 28: Overall performance · No
|
0 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Performance: Chronic and Dehisced Surgical Wounds Only
Day 28: Comfort during wear · Yes
|
13 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Performance: Chronic and Dehisced Surgical Wounds Only
Day 28: Comfort during wear · No
|
0 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Performance: Chronic and Dehisced Surgical Wounds Only
Day 28: Noise level · Yes
|
13 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Performance: Chronic and Dehisced Surgical Wounds Only
Day 28: Noise level · No
|
0 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Performance: Chronic and Dehisced Surgical Wounds Only
Day 28: Discreetness · Yes
|
13 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Performance: Chronic and Dehisced Surgical Wounds Only
Day 28: Discreetness · No
|
0 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Performance: Chronic and Dehisced Surgical Wounds Only
Day 28: Portability · Yes
|
13 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Performance: Chronic and Dehisced Surgical Wounds Only
Day 28: Portability · No
|
0 Participants
|
—
|
—
|
SECONDARY outcome
Timeframe: Day 14 and Day 28Population: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Chronic and Dehisced Surgical Wounds only.
Patient satisfaction during wear in interference with daily living at Day 14 and Day 28 measured by response of 'Yes' or 'No' to the following: * Showering * Sleeping * Socializing * Working
Outcome measures
| Measure |
PICO 14 Closed Incisions
n=15 Participants
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
|---|---|---|---|
|
Patient Satisfaction During Wear - Interference With Daily Living: Chronic and Dehisced Surgical Wounds Only
Day 14: Showering · Yes
|
8 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Interference With Daily Living: Chronic and Dehisced Surgical Wounds Only
Day 14: Showering · No
|
6 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Interference With Daily Living: Chronic and Dehisced Surgical Wounds Only
Day 14: Sleeping · Yes
|
15 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Interference With Daily Living: Chronic and Dehisced Surgical Wounds Only
Day 14: Sleeping · No
|
0 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Interference With Daily Living: Chronic and Dehisced Surgical Wounds Only
Day 14: Socializing · Yes
|
14 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Interference With Daily Living: Chronic and Dehisced Surgical Wounds Only
Day 14: Socializing · No
|
1 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Interference With Daily Living: Chronic and Dehisced Surgical Wounds Only
Day 14: Working · Yes
|
7 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Interference With Daily Living: Chronic and Dehisced Surgical Wounds Only
Day 14: Working · No
|
7 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Interference With Daily Living: Chronic and Dehisced Surgical Wounds Only
Day 28: Showering · Yes
|
8 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Interference With Daily Living: Chronic and Dehisced Surgical Wounds Only
Day 28: Showering · No
|
5 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Interference With Daily Living: Chronic and Dehisced Surgical Wounds Only
Day 28: Sleeping · Yes
|
13 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Interference With Daily Living: Chronic and Dehisced Surgical Wounds Only
Day 28: Sleeping · No
|
0 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Interference With Daily Living: Chronic and Dehisced Surgical Wounds Only
Day 28: Socializing · Yes
|
12 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Interference With Daily Living: Chronic and Dehisced Surgical Wounds Only
Day 28: Socializing · No
|
1 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Interference With Daily Living: Chronic and Dehisced Surgical Wounds Only
Day 28: Working · Yes
|
8 Participants
|
—
|
—
|
|
Patient Satisfaction During Wear - Interference With Daily Living: Chronic and Dehisced Surgical Wounds Only
Day 28: Working · No
|
5 Participants
|
—
|
—
|
SECONDARY outcome
Timeframe: Up to 28 daysPopulation: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Chronic and Dehisced Surgical Wounds only.
Ease of application and removal of the PICO 14 dressing for Chronic and Dehisced Surgical Wounds determined by overall count of dressings applied/removed based on responses to the questions "Was it easy to apply the dressing" and "Was it easy to remove the dressing" as either 'Yes' or 'No'.
Outcome measures
| Measure |
PICO 14 Closed Incisions
n=113 dressings
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
|---|---|---|---|
|
Ease of Application and Removal: Chronic and Dehisced Surgical Wounds Only
Was it easy to apply the dressing · Yes
|
112 dressings
|
—
|
—
|
|
Ease of Application and Removal: Chronic and Dehisced Surgical Wounds Only
Was it easy to apply the dressing · No
|
1 dressings
|
—
|
—
|
|
Ease of Application and Removal: Chronic and Dehisced Surgical Wounds Only
Was it easy to remove the dressing · Yes
|
105 dressings
|
—
|
—
|
|
Ease of Application and Removal: Chronic and Dehisced Surgical Wounds Only
Was it easy to remove the dressing · No
|
4 dressings
|
—
|
—
|
SECONDARY outcome
Timeframe: Up to 28 daysPopulation: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Chronic and Dehisced Surgical Wounds only.
Dressing wear time in days summarized for Chronic and Dehisced Surgical Wounds over the treatment period up to 28 days.
Outcome measures
| Measure |
PICO 14 Closed Incisions
n=114 dressings
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
|---|---|---|---|
|
Dressing Wear Time: Chronic and Dehisced Surgical Wounds Only
|
3.6 days
Standard Deviation 2.0
|
—
|
—
|
SECONDARY outcome
Timeframe: Up to 28 daysPopulation: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Chronic and Dehisced Surgical Wounds only.
Dressing conformability to the wound measured by the number of responses to the question "Was the dressing conformable on the incision/wound?" as either 'Yes' or 'No'.
Outcome measures
| Measure |
PICO 14 Closed Incisions
n=112 dressings
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
|---|---|---|---|
|
Dressing Conformability: Chronic and Dehisced Surgical Wounds Only
Yes
|
112 dressings
|
—
|
—
|
|
Dressing Conformability: Chronic and Dehisced Surgical Wounds Only
No
|
0 dressings
|
—
|
—
|
SECONDARY outcome
Timeframe: Up to 28 daysPopulation: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Chronic and Dehisced Surgical Wounds only.
Dressing change frequency summarized as the number of dressings used per participant for Chronic and Dehisced Surgical Wounds
Outcome measures
| Measure |
PICO 14 Closed Incisions
n=16 Participants
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
|---|---|---|---|
|
Number of Dressings Used: Chronic and Dehisced Surgical Wounds Only
|
7.1 dressings per participant
Standard Deviation 3.3
|
—
|
—
|
SECONDARY outcome
Timeframe: Up to 28 daysPopulation: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Chronic and Dehisced Surgical Wounds only.
Reason for dressing change for Chronic and Dehisced Surgical Wounds only. Count of occurrences by dressing were categorized as 'Yes' or 'No': * Routine dressing change * Inadequate exudate management * Pain/discomfort * Dressing damaged * Dressing fell off * Patient removed dressing * Adverse Event * Surgical procedure * Safety alarm * Dressing components not in place * No vacuum * other
Outcome measures
| Measure |
PICO 14 Closed Incisions
n=114 dressings
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
|---|---|---|---|
|
Reason for Dressing Change: Chronic and Dehisced Surgical Wounds Only
Inadequate exudate management · Yes
|
8 dressings
|
—
|
—
|
|
Reason for Dressing Change: Chronic and Dehisced Surgical Wounds Only
Inadequate exudate management · No
|
106 dressings
|
—
|
—
|
|
Reason for Dressing Change: Chronic and Dehisced Surgical Wounds Only
Dressing damaged · Yes
|
0 dressings
|
—
|
—
|
|
Reason for Dressing Change: Chronic and Dehisced Surgical Wounds Only
Dressing damaged · No
|
114 dressings
|
—
|
—
|
|
Reason for Dressing Change: Chronic and Dehisced Surgical Wounds Only
Dressing fell off · Yes
|
3 dressings
|
—
|
—
|
|
Reason for Dressing Change: Chronic and Dehisced Surgical Wounds Only
Dressing fell off · No
|
111 dressings
|
—
|
—
|
|
Reason for Dressing Change: Chronic and Dehisced Surgical Wounds Only
Patient removed dressing · Yes
|
0 dressings
|
—
|
—
|
|
Reason for Dressing Change: Chronic and Dehisced Surgical Wounds Only
Patient removed dressing · No
|
114 dressings
|
—
|
—
|
|
Reason for Dressing Change: Chronic and Dehisced Surgical Wounds Only
Adverse Event · Yes
|
2 dressings
|
—
|
—
|
|
Reason for Dressing Change: Chronic and Dehisced Surgical Wounds Only
Adverse Event · No
|
112 dressings
|
—
|
—
|
|
Reason for Dressing Change: Chronic and Dehisced Surgical Wounds Only
Surgical procedure · Yes
|
0 dressings
|
—
|
—
|
|
Reason for Dressing Change: Chronic and Dehisced Surgical Wounds Only
Surgical procedure · No
|
114 dressings
|
—
|
—
|
|
Reason for Dressing Change: Chronic and Dehisced Surgical Wounds Only
Safety alarm · Yes
|
2 dressings
|
—
|
—
|
|
Reason for Dressing Change: Chronic and Dehisced Surgical Wounds Only
Safety alarm · No
|
112 dressings
|
—
|
—
|
|
Reason for Dressing Change: Chronic and Dehisced Surgical Wounds Only
Dressing components not in place · Yes
|
0 dressings
|
—
|
—
|
|
Reason for Dressing Change: Chronic and Dehisced Surgical Wounds Only
Dressing components not in place · No
|
114 dressings
|
—
|
—
|
|
Reason for Dressing Change: Chronic and Dehisced Surgical Wounds Only
No vacuum · Yes
|
3 dressings
|
—
|
—
|
|
Reason for Dressing Change: Chronic and Dehisced Surgical Wounds Only
No vacuum · No
|
111 dressings
|
—
|
—
|
|
Reason for Dressing Change: Chronic and Dehisced Surgical Wounds Only
Other · Yes
|
17 dressings
|
—
|
—
|
|
Reason for Dressing Change: Chronic and Dehisced Surgical Wounds Only
Other · No
|
97 dressings
|
—
|
—
|
|
Reason for Dressing Change: Chronic and Dehisced Surgical Wounds Only
Routine dressing change · Yes
|
84 dressings
|
—
|
—
|
|
Reason for Dressing Change: Chronic and Dehisced Surgical Wounds Only
Routine dressing change · No
|
30 dressings
|
—
|
—
|
|
Reason for Dressing Change: Chronic and Dehisced Surgical Wounds Only
Pain/discomfort · Yes
|
0 dressings
|
—
|
—
|
|
Reason for Dressing Change: Chronic and Dehisced Surgical Wounds Only
Pain/discomfort · No
|
114 dressings
|
—
|
—
|
SECONDARY outcome
Timeframe: Day 28Population: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Chronic and Dehisced Surgical Wounds only.
Acceptability of the device determined from the clinician's response (Yes/No) at discontinuation of therapy by participant (i.e., Day 28) to the question: Overall are you satisfied with the performance of the PICO 14 system (pump and PICO 14 dressing)?
Outcome measures
| Measure |
PICO 14 Closed Incisions
n=13 Participants
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
|---|---|---|---|
|
Clinician Acceptability of PICO 14 at Discontinuation of Therapy: Chronic and Dehisced Surgical Wounds Only
Yes
|
13 Participants
|
—
|
—
|
|
Clinician Acceptability of PICO 14 at Discontinuation of Therapy: Chronic and Dehisced Surgical Wounds Only
No
|
0 Participants
|
—
|
—
|
Adverse Events
PICO 14 Closed Incisions
PICO 14 Chronic/Dehisced Surgical Wounds
Serious adverse events
| Measure |
PICO 14 Closed Incisions
n=25 participants at risk
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Chronic/Dehisced Surgical Wounds
n=19 participants at risk
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
|---|---|---|
|
Blood and lymphatic system disorders
ANEMIA
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Respiratory, thoracic and mediastinal disorders
ADMITTED TO HOSPITAL WITH A CHEST INFECTION.
|
0.00%
0/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
5.3%
1/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
General disorders
PATIENTS GENERAL HEALTH HAS QUICKLY DECLINED AND IS NOW AT END OF LIFE
|
0.00%
0/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
5.3%
1/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
General disorders
PATIENT HOSPITALISED WITH CHEST PAIN
|
0.00%
0/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
5.3%
1/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Infections and infestations
WOUND INFECTION
|
0.00%
0/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
5.3%
1/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
Other adverse events
| Measure |
PICO 14 Closed Incisions
n=25 participants at risk
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
PICO 14 Chronic/Dehisced Surgical Wounds
n=19 participants at risk
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up.
PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
|
|---|---|---|
|
General disorders
ABDOMINAL DISCOMFORT
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Gastrointestinal disorders
ABDOMINAL PAIN
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Renal and urinary disorders
ACUTE KIDNEY INJURY
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Blood and lymphatic system disorders
ANAEMIA POST SURGERY
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Skin and subcutaneous tissue disorders
BLISTER ON RIGHT EDGE OF ADHESIVE STRIP
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Skin and subcutaneous tissue disorders
BLISTER TO BELLY BUTTON
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Vascular disorders
BLOOD STAINED SPUTUM
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
General disorders
BP 106/47- HYPOTENSION
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Cardiac disorders
BRADYCARDIA
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Respiratory, thoracic and mediastinal disorders
CHEST INFECTION
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Skin and subcutaneous tissue disorders
CONGESTIVE DERMATITIS OF THE LOWER LEGS
|
0.00%
0/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
5.3%
1/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Gastrointestinal disorders
CONSTIPATION
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Gastrointestinal disorders
DIARRHOEA
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Gastrointestinal disorders
DISTENDED ABDOMEN
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
General disorders
DRAIN SITE OOZING PUS AND RED
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Skin and subcutaneous tissue disorders
DRESSING STUCK TO THE WOUND AND CAUSED SOME EXCORIATION TO THE SURROUNDING SKIN
|
0.00%
0/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
5.3%
1/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Nervous system disorders
DROWSINESS
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
General disorders
ELEVATED INFLAMMATORY MARKERS
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Blood and lymphatic system disorders
ELEVATED WHITE BLOOD CELL COUNT POST-OPERATIVELY
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Skin and subcutaneous tissue disorders
EXCORIATION TO SURROUNDING SKIN TO WOUND
|
0.00%
0/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
5.3%
1/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Vascular disorders
EXTENSIVE BRUISING TO OPERATED LEG
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Nervous system disorders
FAINT DAY 9 POST-OPERATIVELY
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Injury, poisoning and procedural complications
FALL AT HOME- HIT HEAD
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Psychiatric disorders
FEELING GENERALLY UNWELL
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
General disorders
FEELING ROUGH
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Gastrointestinal disorders
FRANK RECTAL BLEED
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Vascular disorders
HAEMATOMA AT WOUND SITE
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Renal and urinary disorders
HAEMATURIA ON CATHETER REMOVAL
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Blood and lymphatic system disorders
HB 97
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Nervous system disorders
HEADACHES
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Endocrine disorders
HYPERGLYCAEMIA
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Endocrine disorders
HYPOGLYCEMIA
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Endocrine disorders
HYPOKALAEMIA
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
General disorders
HYPOTENSION
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Gastrointestinal disorders
ILEOSTOMY LEAK INTO WOUND DRESSING
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
General disorders
ILEUS
|
12.0%
3/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Vascular disorders
INFECTED HAEMATOMA
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
General disorders
LEFT ELBOW PAIN. NUMBNESS TI RING & LITTLE FINGER
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Gastrointestinal disorders
LOOSE BOWELS
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Gastrointestinal disorders
LOOSE STOOL
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Gastrointestinal disorders
LOOSE STOOL INCONTINENCE
|
0.00%
0/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
5.3%
1/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Renal and urinary disorders
LOW EGFR
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Endocrine disorders
LOW MAGNESIUM
|
8.0%
2/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Endocrine disorders
LOW PHOSPHATE
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Blood and lymphatic system disorders
LOW POST-OPERATIVE SODIUM
|
8.0%
2/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Endocrine disorders
LOW POTASSIUM
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Endocrine disorders
LOW SODIUM LEVEL
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
General disorders
LOW TEMPERATURE
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Skin and subcutaneous tissue disorders
MACERATED WOUND EDGES
|
0.00%
0/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
5.3%
1/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Gastrointestinal disorders
MELENA
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Nervous system disorders
MIGRAINE
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Musculoskeletal and connective tissue disorders
MILD CRAMPS
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
General disorders
MILD PAIN
|
8.0%
2/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Immune system disorders
MONOCYTES: 0.9 HB: 102 WBC: 14.7 NEUTROPHILS: 11.7 CREATINE: 91 E-GFR/1.73M*2 50
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Gastrointestinal disorders
NAUSEA
|
44.0%
11/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Respiratory, thoracic and mediastinal disorders
NONE PRODUCTIVE COUGH
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
General disorders
OEDEMA- ANKLES
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Skin and subcutaneous tissue disorders
ON ARRIVAL WAS FOUND TO HAVE 2 X MOISTURE LESIONS TO SKIN
|
0.00%
0/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
5.3%
1/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
General disorders
OOZING DRAIN WOUND SITE
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Gastrointestinal disorders
PAIN
|
12.0%
3/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
General disorders
PAIN AROUND WOUND SITE AFTER REMOVAL OF CLIPS
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Gastrointestinal disorders
PAIN CENTRAL ABDOMEN
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
General disorders
PAIN ON REMOVAL OF DRESSING
|
0.00%
0/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
5.3%
1/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Injury, poisoning and procedural complications
PAIN OPERATED SITE
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
General disorders
PAIN OPERATIVE SITE
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
General disorders
PAIN RIGHT SIDE
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
General disorders
PAIN VAS 6-8 IN OPERATED KNEE
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Injury, poisoning and procedural complications
PAINFUL FOOT WHEN TWISTED ANKLE DURING A FALL
|
0.00%
0/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
5.3%
1/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Psychiatric disorders
PANIC ATTACKS
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
General disorders
PARTICIPANT FINDING PICO14 DRESSING UNCOMFOTABLE, DISTURBING SLEEP
|
0.00%
0/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
5.3%
1/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
General disorders
PAIN FROM COCCYX NOT WOUND SITE AS ADHESIVE STRIPS TOUCH COCCYX (PAIN IN COCCYX FROM PREVIOUS FALL)
|
0.00%
0/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
5.3%
1/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Gastrointestinal disorders
PASSED FRESH BLOOD PER RECTUM
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Nervous system disorders
PATIENT DESCRIBES INTERMITTENT COOLING SENSATION ON FOOT OF OPERATED LEG
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Infections and infestations
PATIENT HAD COVID
|
0.00%
0/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
5.3%
1/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Respiratory, thoracic and mediastinal disorders
PATIENT PRESENTED AND TREATED FOR ONGOING EXACERBATED COPD SYMPTOMS & SUSPECTED CHEST INFECTION
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Renal and urinary disorders
POOR URINE OUTPUT
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Blood and lymphatic system disorders
POST-OPERATIVE ANAEMIA
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Skin and subcutaneous tissue disorders
POST-OPERATIVE ITCH
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
General disorders
POSTURAL DROP HYPOTENSION
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Injury, poisoning and procedural complications
PRESSURE DAMAGE TO THE DORSAL CREASE FROM STOCKING MOVEMENT AND CREASING OVER AREA
|
0.00%
0/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
5.3%
1/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Endocrine disorders
RAISED BLOOD SUGAR 9.6
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
General disorders
RAISED C-REACTIVE PROTEIN
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Renal and urinary disorders
RAISED CREATININE
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
General disorders
RAISED POST-OPERATIVE WHITE BLOOD CELLS
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Blood and lymphatic system disorders
RAISED RED BLOOD COUNT
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Immune system disorders
RAISED WHITE BLOOD COUNT
|
8.0%
2/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Gastrointestinal disorders
RECTAL BLEED
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Skin and subcutaneous tissue disorders
REDDEN AREA LEFT HEEL DUE TO PRESSURE, SKIN IS NOT BROKEN
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Respiratory, thoracic and mediastinal disorders
REDUCED O2 SATURATIONS
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Skin and subcutaneous tissue disorders
SEVERE ITCHING ON SURGICAL SITE
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Skin and subcutaneous tissue disorders
SKIN IRRITATION UNDER THE BANDAGE
|
0.00%
0/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
5.3%
1/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Skin and subcutaneous tissue disorders
SKIN RASH FORMED POST-OP, CLUSTERED IN DENSE LINES & AREAS OF SKIN ACROSS RIGHT-SID CHEST & SHOULDER
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Blood and lymphatic system disorders
SLIGHT POST-OPERATIVE ANAEMIA
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Gastrointestinal disorders
SLUGGISH BOWEL
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
General disorders
SMALL BOWEL LOOP OBSTRUCTION
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Skin and subcutaneous tissue disorders
SMALL BRUISING/DEEP TISSUE INJURY TO LEFT EDGE OF WOUND
|
0.00%
0/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
5.3%
1/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
General disorders
SORE NOSE DUE TO NASOJEJUNAL AND NASOGASTRIC TUBE
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
General disorders
SUPERFICIAL WOUND DEHISCENE
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
General disorders
SWELLING LOWER LEG
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Cardiac disorders
TACHYCARDIA
|
12.0%
3/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Skin and subcutaneous tissue disorders
TRAUMA TO WOUND BED ON REMOVAL OF DRESSING
|
0.00%
0/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
5.3%
1/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Gastrointestinal disorders
TYPE 7 STOOL- DIARRHEA
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Renal and urinary disorders
URINARY RETENTION
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Renal and urinary disorders
URINARY TRACT INFECTION
|
8.0%
2/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Renal and urinary disorders
URINE CONCENTRATED
|
8.0%
2/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Nervous system disorders
VACANT EPISODE
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Nervous system disorders
VASOVAGAL
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Nervous system disorders
VERY DIZZY
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Gastrointestinal disorders
VOMITING
|
20.0%
5/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Gastrointestinal disorders
VOMITTED GREEN FLUID
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Blood and lymphatic system disorders
WHITE CELL COUNT ELEVATED POST-OPERATIVELY
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Gastrointestinal disorders
WIND LIKE UPPER ABDOMINAL PAIN
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Gastrointestinal disorders
WIND PAIN
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
|
Injury, poisoning and procedural complications
WOUND INFECTION
|
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place
Restriction type: LTE60